These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33072574)

  • 21. Protocol for Standardizing High-to-Moderate Abundance Protein Biomarker Assessments Through an MRM-with-Standard-Peptides Quantitative Approach.
    Percy AJ; Yang J; Chambers AG; Mohammed Y; Miliotis T; Borchers CH
    Adv Exp Med Biol; 2016; 919():515-530. PubMed ID: 27975233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients.
    Mustafa GM; Larry D; Petersen JR; Elferink CJ
    World J Hepatol; 2015 Jun; 7(10):1312-24. PubMed ID: 26052377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.
    Whiteaker JR; Zhang H; Zhao L; Wang P; Kelly-Spratt KS; Ivey RG; Piening BD; Feng LC; Kasarda E; Gurley KE; Eng JK; Chodosh LA; Kemp CJ; McIntosh MW; Paulovich AG
    J Proteome Res; 2007 Oct; 6(10):3962-75. PubMed ID: 17711321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive and Scalable Highly Automated MS-Based Proteomic Workflow for Clinical Biomarker Discovery in Human Plasma.
    Dayon L; Núñez Galindo A; Corthésy J; Cominetti O; Kussmann M
    J Proteome Res; 2014 Aug; 13(8):3837-3845. PubMed ID: 25058407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absolute quantitation of proteins in human blood by multiplexed multiple reaction monitoring mass spectrometry.
    Percy AJ; Chambers AG; Parker CE; Borchers CH
    Methods Mol Biol; 2013; 1000():167-89. PubMed ID: 23585092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and Validation of Multiple Reaction Monitoring (MRM) Assays for Clinical Applications.
    Kontostathi G; Makridakis M; Bitsika V; Tsolakos N; Vlahou A; Zoidakis J
    Methods Mol Biol; 2019; 1959():205-223. PubMed ID: 30852825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted proteomics: a bridge between discovery and validation.
    Harlan R; Zhang H
    Expert Rev Proteomics; 2014 Dec; 11(6):657-61. PubMed ID: 25348939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Protein Quantification in a Complex Background by DIA and TMT Workflows with Fixed Instrument Time.
    Muntel J; Kirkpatrick J; Bruderer R; Huang T; Vitek O; Ori A; Reiter L
    J Proteome Res; 2019 Mar; 18(3):1340-1351. PubMed ID: 30726097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics.
    Kitteringham NR; Jenkins RE; Lane CS; Elliott VL; Park BK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(13):1229-39. PubMed ID: 19041286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid label-free profiling of oral cancer biomarker proteins using nano-UPLC-Q-TOF ion mobility mass spectrometry.
    Nassar AF; Williams BJ; Yaworksy DC; Patel V; Rusling JF
    Proteomics Clin Appl; 2016 Mar; 10(3):280-9. PubMed ID: 26684082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary biomarker discovery in gliomas using mass spectrometry-based clinical proteomics.
    Wu J; Zhang J; Wei J; Zhao Y; Gao Y
    Chin Neurosurg J; 2020; 6():11. PubMed ID: 32922940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Affinity Proteomics for Fast, Sensitive, Quantitative Analysis of Proteins in Plasma.
    O'Grady JP; Meyer KW; Poe DN
    Methods Mol Biol; 2017; 1619():55-61. PubMed ID: 28674877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Verification of the biomarker candidates for non-small-cell lung cancer using a targeted proteomics approach.
    Kim YJ; Sertamo K; Pierrard MA; Mesmin C; Kim SY; Schlesser M; Berchem G; Domon B
    J Proteome Res; 2015 Mar; 14(3):1412-9. PubMed ID: 25597550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Qualification and Verification of Protein Biomarker Candidates.
    Zhao Y; Brasier AR
    Adv Exp Med Biol; 2016; 919():493-514. PubMed ID: 27975232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted Phosphoproteome Analysis Using Selected/Multiple Reaction Monitoring (SRM/MRM).
    Adachi J; Narumi R; Tomonaga T
    Methods Mol Biol; 2016; 1394():87-100. PubMed ID: 26700043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges and Opportunities in Clinical Applications of Blood-Based Proteomics in Cancer.
    Bhawal R; Oberg AL; Zhang S; Kohli M
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32867043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum.
    Lopez MF; Kuppusamy R; Sarracino DA; Prakash A; Athanas M; Krastins B; Rezai T; Sutton JN; Peterman S; Nicolaides K
    J Proteome Res; 2011 Jan; 10(1):133-42. PubMed ID: 20499897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Applications of multiple reaction monitoring targeted proteomics assays in human plasma.
    Kontostathi G; Makridakis M; Zoidakis J; Vlahou A
    Expert Rev Mol Diagn; 2019 Jun; 19(6):499-515. PubMed ID: 31057016
    [No Abstract]   [Full Text] [Related]  

  • 40. iTRAQ-based quantitative analysis of age-specific variations in salivary proteome of caries-susceptible individuals.
    Wang K; Wang X; Zheng S; Niu Y; Zheng W; Qin X; Li Z; Luo J; Jiang W; Zhou X; Li W; Zhang L
    J Transl Med; 2018 Oct; 16(1):293. PubMed ID: 30359274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.